David Dodd | executive |
Mark Reynolds | executive |
Robert LeBoyer | analyst |
Kelly McKee | executive |
John Sharkey | executive |
Good afternoon, and welcome, everyone, to the GeoVax First Quarter 2024 Corporate Update Call. My name is Mark, and I will facilitate today's call. With me are David Dodd, Chairman and CEO; Mark Reynolds, Chief Financial Officer; Mark Newman, PHD, Chief Antti Officer; Kelly McKee, MBA, Chief Medical Officer; and John Sharkey, PHD, Vice President, Business Development. [Operator Instructions].
As a reminder, this conference is being recorded. At this time, I am turning the call over to Max Gadicke, SternIR.